本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

72.81
+0.11000.15%
成交量:41.41万
成交额:3,011.61万
市值:31.95亿
市盈率:-67.27
高:73.08
开:72.88
低:71.77
收:72.70
52周最高:85.25
52周最低:48.20
股本:4,388.30万
流通股本:3,267.99万
量比:0.67
换手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
净资产收益率:-13.68%
总资产收益率:-5.48%
市净率:9.21
市盈率(LYR):-45.79

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/13

重要事件披露

Form 8-K - Current report
2026/07/08

重要事件披露

Form 8-K - Current report
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities